SIRT2 and hepatocellular carcinoma: Next, we used pilot data of MYC expression levels and liver histology in Sirt2+/+ HCC mice to establish 17-, 36-, and 48-days post-c-MYC induction as time points that replicate early-, mid-, and late-stage disease, respectively (Figure 2A).